These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11178440)

  • 1. Is the abnormal toxicity test still relevant for the safety of vaccines, sera and immunoglobulins?
    Krämer B; Nagel M; Duchow K; Schwanig M; Cussler K
    ALTEX; 1996; 13(1):7-16. PubMed ID: 11178440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal toxicity - a relevant safety test under GLP- and GMP-conditions in the production of vaccines?
    Duchow K; Krämer B
    ALTEX; 1994; 11(5):11-18. PubMed ID: 11178400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved abnormal toxicity test by using reference vaccine-specific body weight curves and histopathological data for monitoring vaccine quality and safety in Japan.
    Mizukami T; Masumi A; Momose H; Kuramitsu M; Takizawa K; Naito S; Maeyama J; Furuhata K; Tsuruhara M; Hamaguchi I; Yamaguchi K
    Biologicals; 2009 Jan; 37(1):8-17. PubMed ID: 18805705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the relevance of the target animal safety test for the quality control of veterinary immunological medicinal products.
    Pöbetanecker A; Cubetaler K
    ALTEX; 1998; 15(5):71-75. PubMed ID: 11178548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M
    ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The target animal safety test--is it still relevant?
    Advisory Group on Alternatives to Animal Testing in Immunobiologicals
    Biologicals; 2002 Dec; 30(4):277-87. PubMed ID: 12474863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Historical data analyses and scientific knowledge suggest complete removal of the abnormal toxicity test as a quality control test.
    Garbe JHO; Ausborn S; Beggs C; Bopst M; Joos A; Kitashova AA; Kovbasenco O; Schiller CD; Schwinger M; Semenova N; Smirnova L; Stodart F; Visalli T; Vromans L
    J Pharm Sci; 2014 Nov; 103(11):3349-3355. PubMed ID: 25209378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use.
    Winsnes R; Hendriksen C; Sesardic D; Akkermans A; Daas A
    Dev Biol Stand; 1999; 101():277-88. PubMed ID: 10566802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calibration of European pharmacopoeia biological reference preparation for diphtheria vaccine (adsorbed) batch 4.
    Stickings P; Rigsby P; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):1-9. PubMed ID: 20144448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False positive findings associated with adenoviral vector-based vaccine underscore the regulatory necessity to eliminate abnormal toxicity test.
    Meng R; van Ooij M; Li Y; Zhang Y; Xie J
    Regul Toxicol Pharmacol; 2024 May; 149():105617. PubMed ID: 38561146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacement of the in vivo neutralisation test for efficacy demonstration of tetanus vaccines ad us. vet.
    Rosskopf U; Noeske K; Werner E
    ALTEX; 2005; 22(3):169-74. PubMed ID: 16186992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of product batches (before and after registration). The German approach.
    Jungbäck C
    Dev Biol Stand; 1992; 79():171-4. PubMed ID: 1286753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of transgenic animals in biomedical research in Germany. Part 2: Ethical evaluation of the use of transgenic animals in biomedical research and perspectives for the changeover in research to research animal-free methods].
    Sauer UG; Kolar R; Rusche B
    ALTEX; 2006; 23(1):3-16. PubMed ID: 16477343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final report of the amended safety assessment of Dioscorea Villosa (Wild Yam) root extract.
    Int J Toxicol; 2004; 23 Suppl 2():49-54. PubMed ID: 15513824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of product batches (before and after registration). The French approach.
    Vannier P
    Dev Biol Stand; 1992; 79():179-82. PubMed ID: 1286755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.